Growth Metrics

Conmed (CNMD) Current Assets (2016 - 2026)

Conmed filings provide 17 years of Current Assets readings, the most recent being $670.6 million for Q1 2026.

  • On a quarterly basis, Current Assets rose 4.94% to $670.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $670.6 million, a 4.94% increase, with the full-year FY2025 number at $672.9 million, up 5.13% from a year prior.
  • Current Assets hit $670.6 million in Q1 2026 for Conmed, roughly flat from $672.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $672.9 million in Q4 2025 to a low of $488.3 million in Q1 2022.
  • Median Current Assets over the past 5 years was $625.6 million (2023), compared with a mean of $619.5 million.
  • Biggest five-year swings in Current Assets: surged 30.24% in 2022 and later increased 0.52% in 2025.
  • Conmed's Current Assets stood at $581.2 million in 2022, then increased by 5.92% to $615.6 million in 2023, then increased by 3.96% to $640.0 million in 2024, then increased by 5.13% to $672.9 million in 2025, then fell by 0.34% to $670.6 million in 2026.
  • The last three reported values for Current Assets were $670.6 million (Q1 2026), $672.9 million (Q4 2025), and $662.2 million (Q3 2025) per Business Quant data.